• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载有布他比妥的脂质纳米颗粒,旨在改善炎症组织的麻醉效果。

Lipid nanoparticles loaded with butamben and designed to improve anesthesia at inflamed tissues.

机构信息

Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas - UNICAMP, Campinas, São Paulo, Brazil.

Department of Structural and Functional Biology, Institute of Biology, UNICAMP, Brazil.

出版信息

Biomater Sci. 2021 May 4;9(9):3378-3389. doi: 10.1039/d1bm00077b.

DOI:10.1039/d1bm00077b
PMID:33949447
Abstract

The most frequently used local anesthetics (LA) for local infiltration have an ionizable amine in the range of pH 7.6-8.9. Effective anesthesia of inflamed tissues is a great challenge, especially because the induced local acidosis decreases the fraction of the neutral (more potent) LA species in situ. To solve this limitation, the butyl-substituted benzocaine analogue butamben (BTB) - that has no ionizable amine group close to the physiological pH - could be useful if it was not for its low solubility. To overcome the solubility problem, an optimized formulation for BTB using nanostructured lipid carriers (NLC) was developed by a factorial design and characterized using DLS, XRD, DSC and cryo-EM. The release kinetics and cytotoxicity of the new formulation were measured in vitro, while the in vivo tests assessed its effectiveness on healthy and inflamed tissues, in rats. The optimized NLCBTB formulation showed desirable physicochemical properties (size = 235.6 ± 3.9 nm, polydispersity = 0.182 ± 0.006 and zeta potential = -23.6 ± 0.5 mV), high (99.5%) encapsulation efficiency and stability during 360 days of storage at room temperature. NLCBTB prolonged the release of butamben and decreased its in vitro cytotoxicity without inducing any in vivo toxic alteration. In the inflammatory hyperalgesia model, the NLCBTB formulation showed potential for the management of inflammatory pain, displaying greater analgesic effectiveness (40%) and a prolonged effect.

摘要

最常被用于局部浸润麻醉的局部麻醉剂(LA)在 pH 值 7.6-8.9 范围内具有可电离的胺。对发炎组织进行有效的麻醉是一个巨大的挑战,特别是因为诱导的局部酸中毒会降低中性(更有效)局部麻醉剂物种在局部的比例。为了解决这个限制,如果没有无离子化胺基团接近生理 pH 值的丁基取代苯佐卡因类似物丁卡因(BTB) - 可以使用,如果不是因为它的低溶解度。为了克服溶解度问题,通过因子设计开发了一种使用纳米结构化脂质载体(NLC)的 BTB 优化配方,并使用 DLS、XRD、DSC 和冷冻 EM 进行了表征。新配方的释放动力学和细胞毒性在体外进行了测量,而体内测试评估了其在健康和发炎组织中的有效性,在大鼠中。优化的 NLCBTB 配方表现出理想的物理化学性质(大小 = 235.6 ± 3.9nm、多分散性 = 0.182 ± 0.006 和 zeta 电位 = -23.6 ± 0.5mV)、高(99.5%)包封效率和在室温下储存 360 天的稳定性。NLCBTB 延长了丁卡因的释放并降低了其体外细胞毒性,而不会引起任何体内毒性改变。在炎症性痛觉过敏模型中,NLCBTB 配方显示出管理炎症性疼痛的潜力,表现出更大的镇痛效果(40%)和更长的作用时间。

相似文献

1
Lipid nanoparticles loaded with butamben and designed to improve anesthesia at inflamed tissues.载有布他比妥的脂质纳米颗粒,旨在改善炎症组织的麻醉效果。
Biomater Sci. 2021 May 4;9(9):3378-3389. doi: 10.1039/d1bm00077b.
2
Bupivacaine (S75:R25) Loaded in Nanostructured Lipid Carriers: Factorial Design, HPLC Quantification Method and Physicochemical Stability Study.负载于纳米结构脂质载体中的布比卡因(S75:R25):析因设计、高效液相色谱定量方法及物理化学稳定性研究
Curr Drug Deliv. 2018;15(3):388-396. doi: 10.2174/1567201814666170726101113.
3
Sucupira Oil-Loaded Nanostructured Lipid Carriers (NLC): Lipid Screening, Factorial Design, Release Profile, and Cytotoxicity.甜椒籽油负载的纳米结构化脂质载体(NLC):脂质筛选、析因设计、释放特性和细胞毒性。
Molecules. 2020 Feb 6;25(3):685. doi: 10.3390/molecules25030685.
4
Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.采用Box-Behnken设计开发和优化负载萝卜硫素的纳米结构脂质载体以提高抗癌症口服疗效:体外、离体和体内评估
Artif Cells Nanomed Biotechnol. 2018;46(sup1):15-31. doi: 10.1080/21691401.2017.1408124. Epub 2017 Nov 28.
5
Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.蔗糖酯稳定的固体脂质纳米粒和纳米结构脂质载体。I. 制剂变量对克霉唑负载纳米粒的理化性质、药物释放和稳定性的影响。
Nanotechnology. 2014 Mar 14;25(10):105101. doi: 10.1088/0957-4484/25/10/105101. Epub 2014 Feb 14.
6
Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.基于纳米结构脂质载体(NLC)的丙酸氯倍他索控释局部用凝胶:设计与体内表征
Drug Deliv Transl Res. 2016 Jun;6(3):289-98. doi: 10.1007/s13346-016-0291-1.
7
Benzocaine loaded solid lipid nanoparticles: Formulation design, in vitro and in vivo evaluation of local anesthetic effect.负载苯佐卡因的固体脂质纳米粒:制剂设计、局部麻醉作用的体外和体内评价
Curr Drug Deliv. 2015;12(6):680-92. doi: 10.2174/1567201812666150703115126.
8
Articaine in functional NLC show improved anesthesia and anti-inflammatory activity in zebrafish.阿替卡因在功能性 NLC 中表现出改善的麻醉和抗炎活性在斑马鱼中。
Sci Rep. 2020 Nov 12;10(1):19733. doi: 10.1038/s41598-020-76751-6.
9
Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.氯原酸稳定的阿托伐他汀纳米结构脂质载体(NLC):制剂、设计与体内评价。
Drug Dev Ind Pharm. 2016;42(2):209-20. doi: 10.3109/03639045.2015.1040414. Epub 2015 May 27.
10
Formulation development of lipid nanoparticles: Improved lipid screening and development of tacrolimus loaded nanostructured lipid carriers (NLC).脂质纳米粒的制剂开发:改良的脂质筛选和载他克莫司的纳米结构脂质载体(NLC)的开发。
Int J Pharm. 2020 Feb 25;576:118918. doi: 10.1016/j.ijpharm.2019.118918. Epub 2019 Dec 20.

引用本文的文献

1
Codelivery of Paclitaxel and Cannabidiol in Lipid Nanoparticles Enhances Cytotoxicity against Melanoma Cells.脂质纳米粒中紫杉醇和大麻二酚的共递送增强对黑色素瘤细胞的细胞毒性。
ACS Omega. 2025 May 22;10(21):21568-21580. doi: 10.1021/acsomega.5c00689. eCollection 2025 Jun 3.
2
Fresh Carrier for an Old Topical Local Anesthetic: Benzocaine in Nanostructured Lipid Carriers.新型载体用于局部麻醉老药:纳米结构脂质载体中的苯佐卡因。
ACS Biomater Sci Eng. 2024 Aug 12;10(8):4958-4969. doi: 10.1021/acsbiomaterials.4c00585. Epub 2024 Jul 29.
3
Development of a Versatile Nanostructured Lipid Carrier (NLC) Using Design of Experiments (DoE)-Part II: Incorporation and Stability of Butamben with Different Surfactants.
使用实验设计(DoE)开发通用纳米结构脂质载体(NLC)-第二部分:丁卡因与不同表面活性剂的包封及稳定性
Pharmaceutics. 2024 Jun 27;16(7):863. doi: 10.3390/pharmaceutics16070863.
4
Advances in the use of local anesthetic extended-release systems in pain management.局部麻醉药控释系统在疼痛管理中的应用进展。
Drug Deliv. 2024 Dec;31(1):2296349. doi: 10.1080/10717544.2023.2296349. Epub 2023 Dec 21.
5
Nanomaterial-Based Drug Delivery Systems for Pain Treatment and Relief: From the Delivery of a Single Drug to Co-Delivery of Multiple Therapeutics.用于疼痛治疗与缓解的基于纳米材料的药物递送系统:从单一药物递送到多种治疗剂的共递送
Pharmaceutics. 2023 Sep 13;15(9):2309. doi: 10.3390/pharmaceutics15092309.
6
Recent Research Advances in Nano-Based Drug Delivery Systems for Local Anesthetics.基于纳米的局部麻醉药传递系统的最新研究进展。
Drug Des Devel Ther. 2023 Aug 30;17:2639-2655. doi: 10.2147/DDDT.S417051. eCollection 2023.
7
Docetaxel Loaded in Copaiba Oil-Nanostructured Lipid Carriers as a Promising DDS for Breast Cancer Treatment.多西紫杉醇负载于 Copaiba 油纳米结构化脂质载体作为治疗乳腺癌的有前途的 DDS。
Molecules. 2022 Dec 13;27(24):8838. doi: 10.3390/molecules27248838.
8
Docetaxel and Lidocaine Co-Loaded (NLC-in-Hydrogel) Hybrid System Designed for the Treatment of Melanoma.用于治疗黑色素瘤的多西他赛和利多卡因共载(水凝胶包封纳米脂质载体)混合系统
Pharmaceutics. 2021 Sep 24;13(10):1552. doi: 10.3390/pharmaceutics13101552.
9
Improvement of Butamben Anesthetic Efficacy by the Development of Deformable Liposomes Bearing the Drug as Cyclodextrin Complex.通过开发载有药物环糊精复合物的可变形脂质体提高布坦本的麻醉效果。
Pharmaceutics. 2021 Jun 12;13(6):872. doi: 10.3390/pharmaceutics13060872.